Potential nanomedicinal applications and physicochemical nature of Hyphaene thebaica‐reduced nano‐samaria

Abstract

AbstractHerein we described the biofabrication of samarium oxide nanoparticles (HT‐Sm2O3 NPs) by applying the aqueous fruit extract of Hyphaene thebaica was utilized as an eco‐friendly chelating agent. The prepared NPs were subjected to various physicochemical properties and potential in biomedical applications. X‐ray Diffraction (XRD) pattern revealed sharp peaks that corroborated with the Joint Committee on Powder Diffraction Standards (JCPDS) card no. 00–042‐1464. Crystallite size obtained from Debye–Scherrer approximation and Williamson–Hall (W–H) plot was 28.73 and 69.3 nm, respectively. Optical bandgap was calculated by employing Kubelka–Munk (K–M) function and was found to be ~4.58 eV. Raman shift was observed at 121, 351, 424—, and 561 cm−1. Photoluminescence (PL) spectra revealed two major peaks positioned at 360 and 540 nm. The high‐resolution transmission electron microscopy (HR‐TEM) analysis of HT‐Sm2O3 nanoparticles (NPs) showed that they predominantly have spherical to cuboidal shapes. Additionally, the selected area electron diffraction (SAED) pattern presented spotty rings, indicating a high level of crystallinity in these NPs. The potential nanomedicine applications were studied using diverse bioassays using different treatments. The antioxidant activity demonstrated 45.71% ± 1.13% inhibition at 1000 μg/mL. Brine shrimp lethality assay revealed the highest cytotoxicity of 46.67% ± 3.33% at 1000 μg/mL and LC50 value of 1081 μg/mL. HT‐Sm2O3 NPs exhibited inhibition of angiogenesis (20.41% ± 1.18%) at of 1000 μg/mL. MTT assay results indicated that HT‐Sm2O3 NPs exhibit inhibitory effects on cell lines. Specifically, these NPs showed an IC50 value of 104.6 μg/mL against 3T3 cells. Against MCF‐7 cells, the NPs demonstrated an IC50 value of 413.25 μg/mL. Additionally, in the inhibition of acetylcholinesterase (AChE), the newly synthesized NPs showed an IC50 value of 320 μg/mL. The antidiabetic assessment through α‐glucosidase and α‐amylase inhibition assays revealed, an IC50 value of 380 μg/mL for α‐glucosidase and 952 μg/mL for α‐amylase was calculated. Overall, our study suggested that the Sm2O3 NPs possess moderate anticancer, cholinesterase inhibition, and antidiabetic potential, however, needs further assessment.Research Highlights In this work, nano‐samaria is synthesized using an eco‐friendly and green approach. The nanoparticles were characterized using techniques such as Raman, HR‐TEM, FTIR, DRS, XRD, and so on, and the applications were studied using multiple in vitro bioassays for Diabetes, Alzheimer, and Cancer. The nano‐samaria revealed good potential for potential biomedical applications.